WHO ICTRP trial
The diagnostic value of FAPI PET/CT in staging of newly diagnosed PCa
NL-OMON53628 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON53628 |
|---|---|
| Public title | The diagnostic value of FAPI PET/CT in staging of newly diagnosed PCa |
| Scientific title | The diagnostic value of FAPI PET/CT in staging of newly diagnosed PCa - proFAPI |
| Primary sponsor | Antoni van Leeuwenhoek Ziekenhuis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | Prostate cancer;10038597;Prostate cancer |
| Interventions | ;Diagnostic value;FAPI PET/CT;Prostate cancer;PSMA PET/CT |
| Registration date | Oct 17, 2023 |
| Target size | 30 |
| Secondary IDs | NL83218.041.23 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: